1. Home
  2. LYRA vs PC Comparison

LYRA vs PC Comparison

Compare LYRA & PC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • PC
  • Stock Information
  • Founded
  • LYRA 2005
  • PC 2012
  • Country
  • LYRA United States
  • PC Singapore
  • Employees
  • LYRA N/A
  • PC N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • PC Restaurants
  • Sector
  • LYRA Health Care
  • PC Consumer Discretionary
  • Exchange
  • LYRA Nasdaq
  • PC Nasdaq
  • Market Cap
  • LYRA 11.3M
  • PC 12.5M
  • IPO Year
  • LYRA 2020
  • PC 2024
  • Fundamental
  • Price
  • LYRA $6.41
  • PC $8.16
  • Analyst Decision
  • LYRA Hold
  • PC
  • Analyst Count
  • LYRA 1
  • PC 0
  • Target Price
  • LYRA $16.00
  • PC N/A
  • AVG Volume (30 Days)
  • LYRA 14.8K
  • PC 194.2K
  • Earning Date
  • LYRA 11-11-2025
  • PC 01-01-0001
  • Dividend Yield
  • LYRA N/A
  • PC N/A
  • EPS Growth
  • LYRA N/A
  • PC N/A
  • EPS
  • LYRA N/A
  • PC N/A
  • Revenue
  • LYRA $770,000.00
  • PC $3,345,964.00
  • Revenue This Year
  • LYRA N/A
  • PC N/A
  • Revenue Next Year
  • LYRA $123.46
  • PC N/A
  • P/E Ratio
  • LYRA N/A
  • PC N/A
  • Revenue Growth
  • LYRA N/A
  • PC N/A
  • 52 Week Low
  • LYRA $3.81
  • PC $5.11
  • 52 Week High
  • LYRA $37.50
  • PC $51.57
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 38.58
  • PC 63.54
  • Support Level
  • LYRA $6.15
  • PC $6.62
  • Resistance Level
  • LYRA $6.72
  • PC $7.46
  • Average True Range (ATR)
  • LYRA 0.38
  • PC 0.57
  • MACD
  • LYRA -0.01
  • PC 0.12
  • Stochastic Oscillator
  • LYRA 25.85
  • PC 97.70

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About PC Premium Catering (Holdings) Limited Ordinary Shares

Premium Catering (Holdings) Ltd is a company that conducts its operations through its subsidiary is mainly engaged in food catering for functions, events, and workers in Singapore. Are specialized in Indian, Bangladesh, and Chinese cuisine and all its food products are Halal food which is permissible for consumption by Muslims to consume. Are an ACRA registered company and licensed by SFA to operate and process food business. Serve highquality value-packed food, company deliver's a reliable and dependable service to meet customer's daily meal requirements. The Company recognizes revenue from sales of budgeted prepared meals.

Share on Social Networks: